Clinical Trial Update: Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 3]

View source ↗

Summary

Phase 3 trial assessing mesenchymal stem cell infusion as part of haploidentical hematopoietic stem cell transplantation in patients with hematological malignan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation Complications Hematological Malignancies

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Ankara University | Conditions: Hematopoietic Stem Cell Transplantation | Phase 3 | Status: COMPLETED